Molina Healthcare stock falls as first-half EPS covers 73.5% of 2026 floor
Molina Healthcare (NYSE:MOH) shares fell 9.4% to $200.85 after hours after its first-half adjusted EPS covered 73.5% of its new 2026 EPS floor. Adjusted EPS was $3.86 in the first half versus a $5.25 floor, leaving a $1.39 gap. Premium revenue fell 6% and medical costs rose, with guidance changes tied to Medicaid, Medicare, and Marketplace.
How this was made
The 30-second read
Why it matters
The guidance bridge implies a $1.39 gap, while cost metrics deteriorated (consolidated MCR up to 92.2%, Marketplace MCR 88.9% above expectations), driving a sharp after-hours selloff.
Market read
Traders can reassess 2026 margin path and the probability of clearing the $5.25 floor based on Medicaid rate timing, Marketplace acuity, and Florida start-up cost risk.
What to watch
The article notes Medicare outlook improved by $1.50 and Marketplace fell by the same amount, netting to zero; traders may be over-weighting the bridge gap versus the underlying mix and timing of rate updates.
Background
Molina reported first-half adjusted EPS of $3.86 and introduced a new 2026 adjusted EPS floor of $5.25, then investors focused on how much of that floor was already “booked.”
Ticker impact
Molina shares fell 9.4% after-hours as first-half adjusted EPS of $3.86 covered only 73.5% of its new 2026 $5.25 floor.
Near-term downside risk remains until management clarifies Marketplace acuity, state rate timing, and Florida start-up cost impacts on the remaining 26.5% of the 2026 floor.
The article ties the stock drop directly to the guidance bridge gap ($1.39) and highlights rising MCR (92.2%) plus Marketplace MCR above expectations (88.9%).
Market effects
Reinforces sensitivity of managed-care earnings to Medicaid rate updates versus medical cost trend, and to Marketplace acuity and risk-adjustment effects.
Focus on state Medicaid rate timing and Florida start-up costs can shift expectations for regional utilization and margin trajectories.
Limited direct global spillover, but it contributes to the broader US health-insurance margin narrative.
Counterpoint
The company frames the Medicaid rate versus cost trend as stabilized and expects future rate increases to correct the gap, so the remaining 26.5% of the floor may be achievable.
Key entities
- companyMolina Healthcare, Inc.
Subject of the article; shares fell 9.4% after-hours on guidance floor coverage and cost-pressure details.
- peerUnitedHealth Group Incorporated
Peer cited for a medical cost ratio improvement (86.7%) that set a demanding benchmark.
- peerElevance Health, Inc.
Peer cited for benefit expense ratio rising to 89.7%.
- peerCentene Corporation
Peer referenced as reporting next on July 28, offering another Medicaid-heavy read-through.
